Loading...

TOI ONCOLOGY INSTITUTE INC Investor Conferences 8-K Filing

NCLG

T

ONCOLOGY INSTITUTE INC

(TOI)

2025 8-K

Board Resignation

Investor Presentation

Financial Results Update

Cybersecurity Incident

Financial Results Announced

Director Resignation

Investor Meetings

Financial Statements

Nasdaq Compliance

Private Placement

Securities Agreement

Investor Presentation

Financial Results

Facility Agreement Amendment

Nasdaq Compliance Issue

Financial Results

Financial Results

Delisting Notice

Annual Meeting Stockholders

Earnings Report

Financial Results

Earnings Report

Earnings Report

Compliance Regained

Resignation of Director

Earnings Presentation

Financial Results Announcement

Annual Meeting of Stockholders

Share Repurchase Program

CEO Resignation and Appoint...

Departure of Directors or C...

Earnings Report

Delisting Notice

Earnings Presentation

Earnings Report

External Links:

On November 14, 2025, The Oncology Institute, Inc. filed an 8-K to disclose an investor presentation for upcoming meetings with investors. The presentation is meant to provide insights into the company's strategies and plans.

AI Assistant

ONCOLOGY INSTITUTE INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.